Labetuzumab
|
WikiDoc Resources for Labetuzumab |
|
Articles |
|---|
|
Most recent articles on Labetuzumab Most cited articles on Labetuzumab |
|
Media |
|
Powerpoint slides on Labetuzumab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Labetuzumab at Clinical Trials.gov Clinical Trials on Labetuzumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Labetuzumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Labetuzumab Discussion groups on Labetuzumab Patient Handouts on Labetuzumab Directions to Hospitals Treating Labetuzumab Risk calculators and risk factors for Labetuzumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Labetuzumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Labetuzumab is a humanized monoclonal antibody used to treat cancer.